Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)

NCT03137082 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT03137082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03137082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)
Lead sponsor
Stony Brook University
Phase
Phase 1/2
Overall status
Completed
Start date
July 12, 2017
Completion date
March 31, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abstinence